Researchers measure amiodarone levels in kids to improve dosing
NCT ID NCT03842020
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at how the heart medication amiodarone behaves in children aged 0 to 18 with heart rhythm disorders. Researchers took blood samples from 57 children to measure drug levels and understand how the body processes it. The goal was to find the best dose for children, since there is no standard dosing guideline yet.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- amiodarone
- What this could lead to
- If successful, this could help doctors determine the safest and most effective dose of amiodarone for children with heart rhythm problems.
- What could go wrong
- This is an observational pharmacokinetic study, not a treatment trial. It may not directly change clinical practice, and results may not apply to all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART RHYTHM DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Necker Hospital
Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.